A finding from the cochrane neonatal Review Group shows that supplementation with probiotics significantly reduces the risk of sever necrotizing enterocolitis and mortality in preemies.
Enteral supplementation with probiotics (i.e., Lactobacillus, Bifidobacterium, and Saccharomyces species and Streptococcus thermophilus) significantly reduces the risk of severe (stage 2 or more) necrotizing enterocolitis (NEC) and mortality in premature infants weighing more than 1,000 g at birth.
The finding, representing a change in practice, comes from the Cochrane Neonatal Review Group and their analysis of nine relevant published randomized or quasi-randomized controlled trials including 1,425 infants.
The researchers calculated that enteral probiotic supplementation reduced the incidence of severe NEC by almost 70% (RR 0.32; 95% CI, 0.17–0.60) and the incidence of mortality by more than half (RR 0.43; 95% CI, 0.25–0.75). No important adverse effects were reported. They could not, however, find evidence of a significantly reduced risk for nosocomial sepsis or days on total parenteral nutrition.
Alfaleh K, Bassler D. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2008;(1):CD006181.
Cochrane Update: Probiotics for prevention of necrotizing enterocolitis in preterm infants. Obstet Gynecol. 2008;111:1202-1204.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Study finds pregnancy risks higher with ART in kidney transplant recipients
July 11th 2025Women with kidney transplants who conceive through assisted reproductive technology face increased risks of complications such as hypertension, preterm birth, and cesarean delivery, according to new research.
Read More